Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
11 2019
Historique:
received: 04 02 2019
revised: 15 06 2019
accepted: 24 06 2019
pubmed: 30 6 2019
medline: 28 7 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

Persons with opioid use disorder (OUD) hospitalized with severe, injection-related infections (SIRI) are frequently hospitalized for the duration of IV antibiotic treatment due to concerns regarding their eligibility for outpatient parenteral antimicrobial therapy (OPAT), which is the standard of care for prolonged IV antibiotic courses for patients without drug use. As part of a pilot study, a novel, integrated care model was developed where patients with OUD and SIRI receive addiction consultation and buprenorphine induction while hospitalized, followed by ongoing management in an outpatient clinic that combines office-based opioid treatment with buprenorphine pharmacotherapy and counseling services with OPAT. Through three illustrative case vignettes the outpatient model is described along with challenges, lessons learned and future directions.

Identifiants

pubmed: 31251946
pii: S0091-7435(19)30236-1
doi: 10.1016/j.ypmed.2019.105760
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Narcotic Antagonists 0
Buprenorphine 40D3SCR4GZ

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105760

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001998
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Laura C Fanucchi (LC)

Division of Infectious Disease, Center on Drug and Alcohol Research, University of Kentucky, 845 Angliana Ave., Lexington, KY 40508, United States of America. Electronic address: laura.fanucchi@uky.edu.

Sharon L Walsh (SL)

Center on Drug and Alcohol Research, University of Kentucky, United States of America.

Alice C Thornton (AC)

Division of Infectious Disease, University of Kentucky, United States of America.

Michelle R Lofwall (MR)

Center on Drug and Alcohol Research, University of Kentucky, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH